1.64
Theratechnologies Inc Aktie (THTX) Neueste Nachrichten
Research Analysts Issue Forecasts for THTX FY2027 Earnings - Defense World
FY2025 EPS Estimates for TSE:TH Reduced by Leede Financial - MarketBeat
Theratechnologies (NASDAQ:THTX) Posts Quarterly Earnings Results, Misses Expectations By $0.14 EPS - MarketBeat
Leede Financial Brokers Reduce Earnings Estimates for TSE:TH - Defense World
Theratechnologies (NASDAQ:THTX) Issues Earnings Results - MarketBeat
Theratechnologies Inc. (NASDAQ:THTX) Short Interest Update - MarketBeat
Theratechnologies Inc. (NASDAQ:THTX) Short Interest Up 212.7% in February - Defense World
Research Analysts Set Expectations for THTX FY2025 Earnings - Defense World
Theratechnologies’ Earnings Call: Growth Amid Challenges - TipRanks
What is Leede Financial's Estimate for THTX FY2025 Earnings? - MarketBeat
Theratechnologies Inc (THTX) Q4 2024 Earnings Call Highlights: Strong EBITDA Turnaround and ... - Yahoo Finance
Theratechnologies Reports Strong Fiscal 2024 Performance - TipRanks
Theratechnologies reports Q4 revenue $25M vs $23.45M last year - TipRanks
Theratechnologies: Fiscal Q4 Earnings Snapshot - mySA
Theratechnologies Inc reports results for the quarter ended November 30Earnings Summary - TradingView
Earnings call transcript: Theratechnologies Q4 2024 sees growth amid strategic shifts - Investing.com UK
Theratechnologies: Fiscal Q4 Earnings Snapshot -February 26, 2025 at 07:55 am EST - Marketscreener.com
Theratechnologies Achieves Record Financial Results and Secures Future Growth - TipRanks
Theratechnologies Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2024 - GlobeNewswire
Theratechnologies Inc (TSX:TH) Q4 2024: Everything You Need to K - GuruFocus.com
Theratechnologies Inc (TSX:TH) Q4 2024: Everything You Need to Know Ahead of Earnings - Yahoo Finance
Theratechnologies Resumes EGRIFTA SV® Distribution Following FDA Approval - TipRanks
Theratechnologies (THTX) Stock Price, News & Analysis - MarketBeat
Theratechnologies (THTX) Expected to Announce Quarterly Earnings on Wednesday - Defense World
Short Interest in Theratechnologies Inc. (NASDAQ:THTX) Drops By 73.4% - MarketBeat
Theratechnologies Announces a Risk of a Temporary Supply Disruption for EGRIFTA SV® in Early 2025 - ADVFN
Theratechnologies (THTX) to Release Quarterly Earnings on Wednesday - MarketBeat
Theratechnologies to Announce Fourth Quarter and Full Year 2024 Financial Results and Provide Business Update - The Manila Times
Theratechnologies to Announce Fourth Quarter and Full Year 2024 Financial Results and Provide ... - Walla Walla Union-Bulletin
Q4 Earnings Preview: Theratechnologies CEO to Unveil Strategic Vision Alongside 2024 Financial Results - StockTitan
Theratechnologies Resumes EGRIFTA SV® Distribution Following FDA Clearance - TipRanks
Major HIV Treatment Back in Stock: FDA Greenlights EGRIFTA SV Distribution to US Pharmacies - StockTitan
Theratechnologies Resumes Distribution of EGRIFTA SV® - GlobeNewswire
Theratechnologies (TSE:TH) Trading Up 1.9%Here's Why - MarketBeat
Theratechnologies (NASDAQ:THTX) vs. Aileron Therapeutics (NASDAQ:ALRN) Head to Head Survey - Defense World
Theratechnologies Inc. (NASDAQ:THTX) Sees Large Decrease in Short Interest - MarketBeat
Theratechnologies (TSE:TH) Stock Passes Above 50-Day Moving AverageShould You Sell? - MarketBeat
Theratechnologies (NASDAQ:THTX) Shares Down 0.6%Time to Sell? - MarketBeat
Theratechnologies (NASDAQ:THTX) Trading Down 0.6% – Time to Sell? - Defense World
Theratechnologies (NASDAQ:THTX) Shares Down 0.6% – Time to Sell? - Defense World
Theratechnologies (TSE:TH) Stock Price Crosses Above 50-Day Moving AverageShould You Sell? - MarketBeat
World Orphan Drug Alliance expands to Canada and full LATAM region, completing the first truly global commercialization offering - GlobeNewswire Inc.
Impending Shortage of Theratechnologies’ EGRIFTA SV® Amid Manufacturing Shutdown - TipRanks
Theratechnologies issues update on Egrifta SV shortage (THTX:NASDAQ) - Seeking Alpha
Theratechnologies Warns of Upcoming Shortage for HIV-Induced Stomach Fat Treatment - MarketWatch
Theratechnologies Provides Update on EGRIFTA SV® Supply - GlobeNewswire
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):